cediranib and lenalidomide in iodine 131-refractory differentiated thyroid cancer
Published 1 year ago • 43 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
57:02
redifferentiation of radioiodine refractory differentiated thyroid cancer
-
2:02
radioiodine-refractory dtc: nccn guidelines
-
2:12
thyroid cancer studies at esmo 2020
-
3:32
24mg versus 18mg starting dose of lenvatinib for differentiated thyroid cancer
-
4:16
treatment options for rai-refractory differentiated thyroid cancer
-
0:29
discover how radioactive iodine is making a big difference for people with thyroid cancer #thyroid
-
3:10
the risks of radioactive iodine treatment in thyroid cancer
-
55:43
cabozantinib for radioiodine-refractory differentiated thyroid cancer with dr. sherman
-
1:02:23
155 systemic therapies in advanced radioactive iodine refractory (non-avid, rai-r) differentiated tc
-
0:57
differentiated thyroid cancer
-
4:09
cosmic-311: cabozantinib versus placebo in patients with radioiodine-refractory differentiated t...
-
7:40
rai-refractory thyroid cancer: new drugs with daniel bowles, m.d.
-
1:00:47
optimizing treatment in differentiated thyroid cancer with dr. newbold
-
3:55
cabozantinib shows efficacy against previously treated differentiated thyroid cancer
-
34:22
radioactive iodine (rai) therapy for rai-refractory disease: “redifferentiation” with dr. sherman
-
2:52
effect of age and lenvatinib on os in thyroid cancer
-
0:55
when is radioactive iodine used for thyroid cancer? #thyroid #thyroidcancer #cancer #hormones
-
27:05
management of differentiated thyroid carcinoma
-
1:02:46
meraiode trial: thyroid cancer breakthrough (brafv600e) w/ dr. leboulleux